Research Articles | Page 3 | Aplastic Anemia & MDS International Foundation

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Research Articles

Article Title Original Publication Date Journal Bone Marrow Disease
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes. Jun 2013 Bone Marrow Transplant myelodysplastic syndromes (MDS)
A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes Oct 2016 Biomed Pharmacother myelodysplastic syndromes (MDS)
A novel marker for screening paroxysmal nocturnal hemoglobinuria using routine complete blood count and cell population data Jan 2015 Ann Lab Med paroxysmal nocturnal hemoglobinuria (PNH)
A Phase 1 Study of Oral ARRY-614, a p38 MAPK/Tie2 Dual Inhibitor, in Patients with Low or Intermediate 1 Risk Myelodysplastic Syndromes Dec 2014 Clin Cancer Res myelodysplastic syndromes (MDS)
A phase 2 trial of high dose lenalidomide in patients with relapsed/refractory higher-risk myelodysplastic syndromes and acute myeloid leukaemia with trilineage dysplasia Oct 2016 Br J Haematol myelodysplastic syndromes (MDS)
A phase 2 trial of the oral smoothened inhibitor glasdegib in refractory myelodysplastic syndromes (MDS) Mar 2019 Leukemia Research myelodysplastic syndromes (MDS)
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes Jun 2017 Leukemia myelodysplastic syndromes (MDS)
A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure Oct 2014 Leuk Res myelodysplastic syndromes (MDS)
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes Mar 2019 Clin Lymphoma Myeloma Leuk myelodysplastic syndromes (MDS)
A plasma microRNA signature as a biomarker for acquired aplastic anemia Sep 2016 Haematologica aplastic anemia